scholarly journals MON-181 Evaluation of the GLUCOCARD Shine Connex Bluetooth Enabled Blood Glucose Monitoring System's Ease of Use

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Julie Walker ◽  
Taylor Thompson ◽  
Patricia Gill ◽  
Raji Shankar

Abstract Background: It is important that a Blood Glucose Monitoring System (BGMS) is easy to use since it is a critical tool used in the self-management of diabetes, including the prevention of micro and macrovascular complications. The “Ease of Use” consumer study is typically evaluated as part of the FDA 510(k) approval process for BGMS. Purpose: The objective of this study was to further verify the Ease of Use of the GLUCOCARD Shine Connex Bluetooth Enabled BGMS. Methods: A total of 20 subjects with confirmed diabetes between the ages of 40 to 89 participated in the IRB-approved study at ARKRAY in Minneapolis, MN during October 2018. 80.0% of the subjects fell between the ages of 60 to 89 years of age. The subjects were asked to perform a fingerstick self-test and answer a questionnaire directed at the Ease of Use of the device and test strip. All the subjects responded to the topics in the questionnaire which included, “Removing a Test Strip from Bottle”, “Inserting a Test Strip into the Meter”, “Removing a Test Strip from the Meter”, “Performing a Blood Glucose Test from your Fingertip” and “Reading Meter Display”. The subjects were asked to rate the topics as Very Easy, Easy, OK, Difficult, or Very Difficult. For evaluation purposes, these topics were grouped as Positive [Very Easy/Easy/OK] and Negative [Difficult/Very Difficult]. Results: From the questionnaire, “Removing a Test Strip from Bottle” and “Inserting a Test Strip into the Meter” received a 95.0% positive rating while all the remaining topics received a 100.0% positive rating, including “Removing a Test Strip from the Meter”, “Performing a Blood Glucose Test from your Fingertip” and “Reading Meter Display”. Conclusion: The GLUCOCARD Shine Connex Bluetooth Enabled BGMS scored a 98.0% positive overall average Ease of Use rating by the subjects.

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 867-P
Author(s):  
STEVEN J. SETFORD ◽  
LAURENCE B. KATZ ◽  
MIKE GRADY ◽  
KIRSTY MACLEOD ◽  
HILARY CAMERON

2011 ◽  
Vol 13 (1) ◽  
pp. 1-10 ◽  
Author(s):  
John Paul Lock ◽  
Ronald Brazg ◽  
Robert M. Bernstein ◽  
Elizabeth Taylor ◽  
Mona Patel ◽  
...  

2018 ◽  
Vol 13 (1) ◽  
pp. 111-117 ◽  
Author(s):  
Stefan Pleus ◽  
Nina Jendrike ◽  
Annette Baumstark ◽  
Jochen Mende ◽  
Cornelia Haug ◽  
...  

Introduction: Blood glucose monitoring systems (BGMS) should provide sufficient analytical quality to allow adequate therapy for diabetes patients. Besides system accuracy, measurement precision is an important aspect of a BGMS’ analytical quality. Methods: Based on ISO 15197:2013/EN ISO 15197:2015, system accuracy, measurement repeatability, and intermediate measurement precision were assessed. ISO 15197:2013 system accuracy criteria require that ⩾95% of individual BGMS’ test strip lot results shall fall within ±15 mg/dl or ±15% of corresponding comparison method results (at glucose concentrations <100 mg/dl and ⩾100 mg/dl, respectively), and that ⩾99% of results fall within consensus error grid (CEG) zones A and B. Measurement repeatability was assessed using venous blood samples, whereas intermediate measurement precision was assessed using control solution samples. Standard deviation (SD) and coefficient of variation (CV) were calculated for glucose concentrations <100 mg/dl and ⩾100 mg/dl, respectively. Precision acceptance criteria are not specified by ISO 15197:2013. Results: All three BGMS fulfilled system accuracy criteria with 96% to 98% of individual test strip lot’s results falling within the acceptable accuracy limits. All measurement results fell within CEG zones A and B. For measurement repeatability, SD was ⩽3.3 mg/dl, and CV was ⩽3.9% for the investigated BGMS. Assessment of intermediate measurement precision showed SD ⩽1.3 mg/dl and CV ⩽3.0%. Conclusion: All three BGMS fulfilled system accuracy criteria of ISO 15197:2013. In absence of acceptance criteria, precision results were found to be consistent with the manufacturer’s labeling of the investigated devices.


Diabetes Care ◽  
1983 ◽  
Vol 6 (6) ◽  
pp. 543-547 ◽  
Author(s):  
S. M. Marshall ◽  
K. G. M. M. Alberti

2018 ◽  
Vol 42 (1) ◽  
pp. 5-10 ◽  
Author(s):  
Lynette Kosar ◽  
Wasem Alsabbagh ◽  
Xinya Lu ◽  
Lisa M. Lix ◽  
Yvonne Shevchuk ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document